deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT03480230

Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Phase II Trial of Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Sponsor: Arafat Tfayli

Conditions Non-Small Cell Lung Cancer Stage
Interventions Compound 121564
Updated 8 times since 2018 Last updated: Aug 13, 2018 Started: Jun 26, 2018 Primary completion: Nov 30, 2022 Completion: Nov 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03480230, this PHASE2 trial focuses on Non-Small Cell Lung Cancer Stage and remains ongoing. Sponsored by Arafat Tfayli, it has been updated 8 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotNot Yet Recruiting~Sep 2018 – ~Jan 2019 · 4 months · monthly snapshotRecruiting~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotRecruiting~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Dec 2022 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Dec 2022 [monthly]

    Recruiting PHASE2

  5. Jan 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

▶ Show 3 earlier versions

  1. Sep 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  2. Jun 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE2

  3. Apr 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Arafat Tfayli
  • Merck KGaA, Darmstadt, Germany
  • Phoenix Clinical Research
Data source: American University of Beirut Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations